Status:
COMPLETED
Surveillance of Ocular Surface Flora (SURFACE)
Lead Sponsor:
Allergan
Conditions:
Cataract
Eligibility:
All Genders
50+ years
Brief Summary
Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteria present on ...
Eligibility Criteria
Inclusion
- Scheduled to undergo cataract surgery
- Able to provide written informed consent
Exclusion
- NSAID in the eye to be swabbed within the past 30 days
- Topical anesthetic, topical antibiotic or antiseptic, or dilating drops in the eye to the swabbed within the past 7 days
- Over-the-counter artificial tear drops or astringent /redness reliever drops (e.g., Visine®, Clear eyes® in the eye to be swabbed on the day of trial
- History of conjunctivitis or any ocular infection within the past 3 months
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
399 Patients enrolled
Trial Details
Trial ID
NCT00621933
Start Date
December 1 2007
End Date
November 1 2008
Last Update
April 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Salt Lake City, Utah, United States